Close Menu

NEW YORK – Bio-Rad Laboratories this week moved a lawsuit alleging patent infringement by 10x Genomics to the US District Court for the District of Massachusetts. The suit, filed Sept. 11 — on the eve of 10x Genomics' initial public offering — alleged that 10x's new line of Next GEM microfluidic chips infringed US Patent No. 8,871,444, licensed by Bio-Rad from Harvard University and the UK's Medical Research Council, among other patents. The firm refiled the case because 10x had objected to the original venue of the US District Court for the District of Delaware.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.